共 50 条
- [1] Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical studyCell Research, 2022, 32 : 995 - 1007Yongxian Hu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterYali Zhou论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterMingming Zhang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterHouli Zhao论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterGuoqing Wei论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterWengang Ge论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterQu Cui论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterQitian Mu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterGong Chen论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterLu Han论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterTingting Guo论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterJiazhen Cui论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXiaoyan Jiang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXiujun Zheng论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterShuhui Yu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXiaolong Li论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXingwang Zhang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterMingxi Chen论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXiuju Li论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterMing Gao论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterKang Wang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterCheng Zu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterHao Zhang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterXiaohong He论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterYanbin Wang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterDongrui Wang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterJiangtao Ren论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation CenterHe Huang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital,Bone Marrow Transplantation Center
- [2] CD7 CAR-T Therapy for Treating CD7-Positive Hematological MalignanciesCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S73 - S74Lu, Peihua论文数: 0 引用数: 0 h-index: 0机构: Lu Daopei, Beijing, Peoples R China Lu Daopei, Beijing, Peoples R China
- [3] Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell MalignanciesBLOOD, 2022, 140 : 4592 - 4594Zhang, Yinqiang论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaLi, Chenggong论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaJiang, Huiwen论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaLuo, Wenjing论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaDu, Mengyi论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaZhou, Fen论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaTang, Lu论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaWu, Jianghua论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaWei, Qiuzhe论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaLu, Cong论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaKou, Haiming论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaWu, Di论文数: 0 引用数: 0 h-index: 0机构: Beijing GoBrd Hosp Management Co Ltd, Beijing, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaAlex, Chang H.论文数: 0 引用数: 0 h-index: 0机构: Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaMei, Heng论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R ChinaHu, Yu论文数: 0 引用数: 0 h-index: 0机构: Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan, Peoples R China
- [4] Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell MalignanciesBLOOD, 2021, 138Ge, Jianning论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaYang, Chunhui论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaSun, Jing论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaChen, Jiao论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaQiu, Shuyi论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaYin, Wenjie论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaShen, Lianjun论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaSersch, Martina论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaCao, Wei论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R ChinaWang, Xinxin论文数: 0 引用数: 0 h-index: 0机构: Gracell Biotechnol, Shanghai, Peoples R China Gracell Biotechnol, Shanghai, Peoples R China
- [5] A Phase I/II Clinical Trial of Piggybac-Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid MalignanciesBLOOD, 2021, 138论文数: 引用数: h-index:机构:Tanaka, Miyuki论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanHasegawa, Aiko论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanInada, Yoichi论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanMorokawa, Hirokazu论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanUsami, Yoko论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanKojima, Shunsuke论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanYanagisawa, Ryu论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanMiyazawa, Chinatsu论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Clin Res, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanIto, Keiko论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Clin Res, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanSakai, Hitoshi论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanNakazawa, Hideyuki论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, JapanTashiro, Haruko论文数: 0 引用数: 0 h-index: 0机构: Teikyo Univ, Sch Med, Dept Hematol Oncol, Itabashi Ku, Tokyo, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan论文数: 引用数: h-index:机构:Nakazawa, Yozo论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan Shinshu Univ, Sch Med, Dept Pediat, Matsumoto, Nagano, Japan
- [6] A Phase I/II Clinical Trial of Piggybac-Modified GMR CAR-T Cell Therapy for CD116 Positive Relapsed/Refractory Myeloid MalignanciesPEDIATRIC BLOOD & CANCER, 2021, 68论文数: 引用数: h-index:机构:Tanaka, Miyuki论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Ctr Adv Res Gene & Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanMorokawa, Hirokazu论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanHirabayashi, Koichi论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanInada, Yoichi论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanUsami, Yoko论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanKojima, Shunsuke论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Ctr Adv Res Gene & Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanYanagisawa, Ryu论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Ctr Adv Res Gene & Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanNakazawa, Hideyuki论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Hematol, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, JapanNakazawa, Yozo论文数: 0 引用数: 0 h-index: 0机构: Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan Shinshu Univ, Ctr Adv Res Gene & Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ Hosp, Ctr Adv Cell Therapy, Matsumoto, Nagano, Japan Shinshu Univ, Dept Pediat, Sch Med, Matsumoto, Nagano, Japan
- [7] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignanciesBLOOD CANCER JOURNAL, 2023, 13 (01)Zhang, Yinqiang论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaLi, Chenggong论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaDu, Mengyi论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaJiang, Huiwen论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaLuo, Wenjing论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaTang, Lu论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaKang, Yun论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaXu, Jia论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaWu, Zhuolin论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaWang, Xindi论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaHuang, Zhongpei论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaZhang, Yanlei论文数: 0 引用数: 0 h-index: 0机构: Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaWu, Di论文数: 0 引用数: 0 h-index: 0机构: Beijing GoBroad Hosp Management Co Ltd, Beijing, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaChang, Alex H. H.论文数: 0 引用数: 0 h-index: 0机构: Shanghai YaKe Biotechnol Ltd, Shanghai, Peoples R China Tongji Univ, Shanghai Pulm Hosp, Clin Translat Res Ctr, Sch Med, Shanghai, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaHu, Yu论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R ChinaMei, Heng论文数: 0 引用数: 0 h-index: 0机构: Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China Hubei Clin Med Ctr Cell Therapy Neoplast Dis, Wuhan 430022, Peoples R China Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan 430022, Peoples R China
- [8] Allogenic and autologous anti-CD7 CAR-T cell therapies in relapsed or refractory T-cell malignanciesBlood Cancer Journal, 13Yinqiang Zhang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeChenggong Li论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeMengyi Du论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeHuiwen Jiang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeWenjing Luo论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeLu Tang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeYun Kang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeJia Xu论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeZhuolin Wu论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeXindi Wang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeZhongpei Huang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeYanlei Zhang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeDi Wu论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeAlex H. Chang论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeYu Hu论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical CollegeHeng Mei论文数: 0 引用数: 0 h-index: 0机构: Huazhong University of Science and Technology,Institute of Hematology, Union Hospital, Tongji Medical College
- [9] Intracellular retention of TCRαβ/CD3 and CD7 to generate novel allogeneic CAR-T cells targeting CD7 for treating T-cell malignanciesJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Li, Jun论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R ChinaLiu, Kaichun论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R ChinaFu, Jianmin论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R ChinaChen, Shanshan论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R ChinaZhang, Yinhang论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R ChinaXu, Guanggui论文数: 0 引用数: 0 h-index: 0机构: Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China Fundamenta Therapeut Co Ltd, Suzhou, Peoples R China
- [10] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapyONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037Zhu, Haibo论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaDeng, Haobin论文数: 0 引用数: 0 h-index: 0机构: Tianjin Med Univ, Cent Clin Coll 1, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaMu, Juan论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaLyu, Cuicui论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaJiang, Yanyu论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R ChinaDeng, Qi论文数: 0 引用数: 0 h-index: 0机构: Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China Nankai Univ, Sch Med, Tianjin Cent Hosp 1, Dept Hematol, Tianjin, Peoples R China